ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,502.35
-0.73%
Dow Jones
44,424.25
-0.32%
Gold vs US Dollar
2,771.73
0.00%
Brent Oil
77.625
0.00%
Bitcoin
104,992.64
0.25%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NewAmsterdam Pharma Company NV (NAMSW)

  7. NewAmsterdam Pharma Company NV (NAMSW) News

NewAmsterdam Pharma Comp... (NAMSW)

NewAmsterdam Pharma Company NV
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NAMSW
DateTimeSourceHeadlineSymbolCompany
10/01/202521:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/01/202513:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/01/202513:00GlobeNewswire Inc.NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic PrioritiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
09/01/202520:38GlobeNewswire Inc.NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NAMSWNewAmsterdam Pharma Company NV
08/01/202522:58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
07/01/202522:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
07/01/202522:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
07/01/202522:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
07/01/202521:29Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/01/202522:56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/01/202522:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/01/202522:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
13/12/202422:16GlobeNewswire Inc.NewAmsterdam Pharma Announces Closing of Upsized $479.0 Million Public Offering of Ordinary Shares and Pre-Funded Warrants, Including Full Exercise of the Underwriters’ Option to Purchase Additional SharesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
13/12/202413:28Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
13/12/202411:33Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAMSWNewAmsterdam Pharma Company NV
12/12/202402:37GlobeNewswire Inc.NewAmsterdam Pharma Announces Pricing of Upsized $416.5 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:NAMSWNewAmsterdam Pharma Company NV
12/12/202400:57Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/12/202421:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/12/202421:34GlobeNewswire Inc.NewAmsterdam Pharma Announces Commencement of $300 Million Public Offering of Ordinary Shares and Pre-Funded WarrantsNASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/12/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/12/202412:24Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
10/12/202412:00GlobeNewswire Inc.NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 BROADWAY Clinical Trial Evaluating Obicetrapib in Patients with Atherosclerotic Cardiovascular Disease and/or Heterozygous Familial HypercholesterolemiaNASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/12/202421:01GlobeNewswire Inc.NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:NAMSWNewAmsterdam Pharma Company NV
20/11/202412:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
20/11/202412:00GlobeNewswire Inc.NewAmsterdam Pharma Announces Positive Topline Data from Pivotal Phase 3 TANDEM Clinical Trial Evaluating the Fixed-Dose Combination of Obicetrapib 10 mg and Ezetimibe 10 mg in Patients with ASCVD or ASCVD Risk Factors and/or HeFHNASDAQ:NAMSWNewAmsterdam Pharma Company NV
18/11/202421:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
18/11/202420:20GlobeNewswire Inc.NewAmsterdam Pharma Presents Additional Data from Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia at AHA Scientific Sessions 2024NASDAQ:NAMSWNewAmsterdam Pharma Company NV
13/11/202421:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/11/202413:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NAMSWNewAmsterdam Pharma Company NV
06/11/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NAMSWNewAmsterdam Pharma Company NV
 Showing the most relevant articles for your search:NASDAQ:NAMSW

Your Recent History

LSE
VAST
Vast Resources
LSE
TERN
Tern
LSE
QBT
Quantum Blockchain Techn...
LSE
GEX
Georgina Energy
LSE
POS
Plexus
LSE
BOO
Boohoo
LSE
BIRD
Blackbird
LSE
GKP
Gulf Keystone Petroleum
LSE
SCLP
Scancell
LSE
PANR
Pantheon Resources
LSE
LLOY
Lloyds Banking
LSE
NFDS
Northern Foods
LSE
BARC
Barclays
LSE
NEXN
Nexxen
LSE
SRSP
Sirius Petroleum
LSE
AXL
Arrow Exploration
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2025 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads